Label at a glance#

ProductAnticoagulant Citrate Dextrose A

Active ingredientDEXTROSE MONOHYDRATE, ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE

Label structure14 sections

Indications and uses

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Dosage and administration

Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Contacts and useful links#

PhoneLabel contact1-800-299-3411

Label contents#

Full prescribing information#

Description

DESCRIPTION SECTION

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A), is a sterile, non-pyrogenic solution of citric acid, sodium citrate, and dextrose, in water for injection. Each 10 mL of solution contains:

Citric Acid, anhydrous, USP	0.073 g
Sodium Citrate, dihydrate, USP	0.220 g
Dextrose, monohydrate, USP	0.245 g
Water for Injection, USP	q.s.
pH: 4.5 – 5.5

single use Single patient use only, on a single occasion.

Clinical Pharmacology

CLINICAL PHARMACOLOGY SECTION

ACD-A acts as an anticoagulant by the action of the citrate ion chelating free ionized calcium, thus making calcium unavailable to the coagulation system.

Indications and Usage

INDICATIONS & USAGE SECTION

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Contraindications

CONTRAINDICATIONS SECTION

NOT FOR DIRECT INTRAVENOUS INFUSION

Warnings

WARNINGS SECTION

NOT FOR DIRECT INTRAVENOUS INFUSION

Precautions

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

Aseptic technique must be maintained at all times.
ACD-A solution is a clear and colorless solution. If the product shows any cloudiness or turbidity, the product should be discarded.
The closure system provides a biological barrier and should be intact – discard product if system is compromised.

Information for Patients

INFORMATION FOR PATIENTS SECTION

None.

Carcinogenesis, mutagenesis, impairment of fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term studies in animals have not been performed to evaluate the carcinogenic potential of ACD-A.

Pregnancy

PREGNANCY SECTION

Long-term studies in animals have not been performed to evaluate the effects of ACD- A on pregnant women.

Pediatric Use

PEDIATRIC USE SECTION

The safety and effectiveness of ACD-A in children have not been established.

Adverse Reactions

ADVERSE REACTIONS SECTION

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).

Overdosage

OVERDOSAGE SECTION

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP systems in production of platelet rich plasma (PRP).

Dosage and Administration

DOSAGE & ADMINISTRATION SECTION

Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Rx Only

SPL UNCLASSIFIED SECTION

Caution: Federal Law (US) restricts this devise to sale by or on the order of a Physician.

How Supplied

HOW SUPPLIED SECTION

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A)

	REF	SIZE	CASE
	PN 9350-10	30 mL	10 Vials/Case
	PN 9350-25	30 mL	25 Vials/Case

STORAGE AND HANDLING SECTION

It is recommended that the product be stored at ambient room temperature, 24 °C (75 °F); however, the product can be stored between 15 °C (59 °F) and 30 °C (86 °F). Protect from freezing and exposure to excessive heat should be minimized.

SPL UNCLASSIFIED SECTION

Manufactured & Distributed by:
CitraLabs™
55 Messina Drive, Braintree, MA 02184
Phone Number: 1-800-299-3411

Authorized Representative:
Biomet Global Supply Chain Center B.V.
Hazeldonk 6530
4836 LD Breda
The Netherlands

Principal Display Panel

PRINCIPAL DISPLAY PANEL - 10 Vial Case Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

C E ₀₀₄₄

ACD-A

Anticoagulant Citrate Dextrose Solution,

10 Vials / Case Solution A, U.S.P., ACD-A, 30 mL

REF PN 9350-10

WARNING: NOT FOR DIRECT INTRAVENOUS INFUSION

Used as an anticoagulant in the extracorporeal blood processing with
Autologous PRP Systems in production of platelet rich plasma (PRP).
Refer to PRP Systems manufacturer's Directions for Use.

Manufactured & Distributed by:

CitraLabs
A Biomet Inc. Company.

Citra Labs, LLC.
55 Messina Drive, Braintree, MA 02184
1-800-299-3411

EC REP

Authorized Representative:
Biomet Global Supply Chain Center B.V.
Hazeldonk 6530
4836 LD Breda
The Netherlands

symbols

STERILE • NON-PYROGENIC
Composition per 10 mL of Solution:
Citric Acid, (Anhydrous), U.S.P. 0.073 g.
Sodium Citrate, (Dihydrate), U.S.P. 0.220 g.
Dextrose, (Monohydrate), U.S.P. 0.245 g.
CAUTION: Single Procedure Use-Discard Unused Portion
Do Not Use Unless Solution is Clear and Seal is Intact.
Store Between 15 °C - 30 °C (59 °F - 86 °F).
RX Only:

EXP DATE

LOT

LA9350-10B 01/20

label

PRINCIPAL DISPLAY PANEL - 25 Vial Case Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

C E ₀₀₄₄

ACD-A

Anticoagulant Citrate Dextrose Solution,

25 Vials / Case Solution A, U.S.P., ACD-A, 30 mL

REF PN 9350-25

WARNING: NOT FOR DIRECT INTRAVENOUS INFUSION

Used as an anticoagulant in the extracorporeal blood processing with
Autologous PRP Systems in production of platelet rich plasma (PRP).
Refer to PRP Systems manufacturer's Directions for Use.

Manufactured & Distributed by:

CitraLabs
A Biomet Inc. Company.

Citra Labs, LLC.
55 Messina Drive, Braintree, MA 02184
1-800-299-3411

EC REP

Authorized Representative:
Biomet Global Supply Chain Center B.V.
Hazeldonk 6530
4836 LD Breda
The Netherlands

symbols

STERILE • NON-PYROGENIC
Composition per 10 mL of Solution:
Citric Acid, (Anhydrous), U.S.P. 0.073 g.
Sodium Citrate, (Dihydrate), U.S.P. 0.220 g.
Dextrose, (Monohydrate), U.S.P. 0.245 g.
CAUTION: Single Procedure Use-Discard Unused Portion
Do Not Use Unless Solution is Clear and Seal is Intact.
Store Between 15 °C - 30 °C (59 °F - 86 °F).
RX Only:

EXP DATE

LOT

LA9350-25 01/20

label

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
ANHYDROUS CITRIC ACID Pharmacologic Class Indexing	3	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cb89b86a-369e-4204-8910-ae797c503af3	Product name	1	20230706
d4880ace-a516-8c47-8dfd-73a4ba5887d7	Product name	2	20180830
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
23731-6051-1	2023-02-14	C162847	48780-1	f386c649-d2f4-0266-e053-dadaa90a7c1a	ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3
23731-6051-2	2023-02-14	C162847	48780-1	f386c649-d2f4-0266-e053-dadaa90a7c1a	ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3
23731-6051-3	2023-02-14	C162847	48780-1	f386c649-d2f4-0266-e053-dadaa90a7c1a	ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3
23731-6051-1	2023-01-30	C162847	48780-1	f386c649-d2f4-0266-e053-dadaa90a7c1a	ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3
23731-6051-2	2023-01-30	C162847	48780-1	f386c649-d2f4-0266-e053-dadaa90a7c1a	ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3
23731-6051-3	2023-01-30	C162847	48780-1	f386c649-d2f4-0266-e053-dadaa90a7c1a	ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
23731-6051-1	Anticoagulant Citrate Dextrose A	10 in 1 CASE	SOLUTION	10	5
23731-6051-2	Anticoagulant Citrate Dextrose A	25 in 1 CASE	SOLUTION	25	5
23731-6051-3	Anticoagulant Citrate Dextrose A	30 mL in 1 VIAL, SINGLE-USE	SOLUTION	30	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
23731-6051	ANTICOAGULANT CITRATE DEXTROSE A (ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE) SOLUTION [CITRA LABS LLC]	5	Current NDC, Legacy NDC, 3 package rows	20230215_5bcd261e-ebba-4ecb-af22-e5aaeb04499b.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
23731-6051-5	ML - Milliliter	23731-6051	fa7599c0-4738-42b4-b126-ddd505bb0628	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Anhydrous Citric Acid	ACTIVE INGREDIENT	XF417D3PSL	2
Dextrose Monohydrate	ACTIVE INGREDIENT	LX22YL083G	2
Trisodium Citrate Dihydrate	ACTIVE INGREDIENT	B22547B95K	2
Anhydrous Citric Acid	ACTIVE MOIETY	XF417D3PSL	2
Anhydrous Dextrose	ACTIVE MOIETY	5SL0G7R0OK	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

Anticoagulant Citrate Dextrose A
Anhydrous Citric Acid, Dextrose Monohydrate, and Trisodium Citrate Dihydrate
DEXTROSE MONOHYDRATE
ANHYDROUS DEXTROSE
ANHYDROUS CITRIC ACID
TRISODIUM CITRATE DIHYDRATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
23731-6051	23731-6051-3, 23731-6051-1, 23731-6051-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
DEXTROSE MONOHYDRATE	LX22YL083G	ACTIB
ANHYDROUS CITRIC ACID	XF417D3PSL	ACTIB
TRISODIUM CITRATE DIHYDRATE	B22547B95K	ACTIM

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020037-001	VOLTAREN	DICLOFENAC SODIUM	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC	AT	RLD, RS	1991-03-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC	AT	RLD, RS	1991-03-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC	AT	RLD, RS	1991-03-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC	AT	RLD, RS	1991-03-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC	AT	RLD, RS	1991-03-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC	AT	RLD, RS	1991-03-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC	AT	RLD, RS	1991-03-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC	AT	RLD, RS	1991-03-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N020037-001	VOLTAREN	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD	1991-03-28	`e64feba35796…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N020037-001	AT	1	`74a2ff9319b5…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020037-001	AT	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020037-001	AT	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020037-001	AT	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020037-001	AT	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020037-001	AT	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020037-001	AT	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020037-001	AT	1	`ea99ee380514…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Anticoagulant Citrate Dextrose A	ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE	Citra Labs LLC	5bcd261e-ebba-4ecb-af22-e5aaeb04499b	2023-02-14	Warnings, Adverse reactions	Exact identifier ndc (package): 23731-6051-2 ndc (package): 23731-6051-1 ndc (package): 23731-6051-3 ndc (product): 23731-6051 ndc11 (package): 23731605102 ndc11 (package): 23731605101 ndc11 (package): 23731605103 spl id: 9a133b17-0377-431f-b839-3e090fdabd78 spl set id: 5bcd261e-ebba-4ecb-af22-e5aaeb04499b